Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Savara Inc SVRA

Healthcare Biotechnology
Savara Inc. is a clinical-stage biopharmaceutical company. The Company is focused on rare respiratory diseases. The Company’s lead program, molgramostim inhalation solution (MOLBREEVI or molgramostim), is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase III development for autoimmune pulmonary alveolar proteinosis (aPAP). MOLBREEVI... see more

Recent & Breaking News (NDAQ:SVRA)

SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire 2 hours ago

SVRA DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Savara Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SVRA

Newsfile 2 days ago

Securities Lawsuit Alert: Savara Inc. (SVRA) Investors - Contact Levi & Korsinsky Before November 7, 2025

ACCESS Newswire 2 days ago

Class Action Filing Initiated by Pomerantz LLP Concerning Savara Inc. - SVRA

ACCESS Newswire 2 days ago

Pomerantz LLP Reminds Shareholders With Losses in Savara Inc. of Legal Deadlines - SVRA

ACCESS Newswire 2 days ago

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Savara Inc.(SVRA) Shareholders

PR Newswire 2 days ago

Shareholders SueWallSt in New Class Action Against Savara Inc. - Act Now

ACCESS Newswire 2 days ago

Shareholders of Savara Inc. (SVRA): Protect Your Rights Before November 7, 2025 - Contact Levi & Korsinsky

ACCESS Newswire 3 days ago

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara

PR Newswire 3 days ago

Class Action Lawsuit Filed: Savara Inc. (SVRA) - Join by November 7, 2025 - Contact Levi & Korsinsky

ACCESS Newswire 3 days ago

Class Action Filed Against Savara Inc. (SVRA) - November 7, 2025 Deadline to Join - Contact Levi & Korsinsky

TheNewsWire 3 days ago

Latest SueWallSt Podcast: What SVRA Investors Need to Know About the Lawsuit

ACCESS Newswire 3 days ago

Investors Urged to Contact Levi & Korsinsky for Information Before November 7, 2025 - Savara Inc. (SVRA)

ACCESS Newswire 3 days ago

SVRA Stockholders Have Opportunity to Lead Savara Inc. Class Action Lawsuit - Contact Bronstein, Gewirtz and Grossman, LLC Today!

ACCESS Newswire 3 days ago

Class Action Filing Pursued by Pomerantz LLP Concerning Savara Inc. - SVRA

ACCESS Newswire 3 days ago

Investors in Savara Inc. (SVRA): Protect Your Rights - Contact Levi & Korsinsky Before November 7, 2025

ACCESS Newswire 3 days ago

Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SVRA

PR Newswire 3 days ago

Investor Alert: Deadline Approaching to Join Savara Inc. (SVRA) Class Action - Contact Levi & Korsinsky

ACCESS Newswire 3 days ago

SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm

PR Newswire 3 days ago

SVRA DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Savara Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SVRA

Newsfile 3 days ago